Advertisement
Screener

Definium Therapeutics, Inc. (DFTX) ROE

Definium Therapeutics, Inc. (DFTX) ROE

  • 2026-06-30: ROE -38.51%.
  • 2026-03-31: ROE -85.19%.
  • 2025-12-31: ROE -55.30%.
  • 2025-09-30: ROE -128.72%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-38.51%
2026-03-31-85.19%
2025-12-31-55.30%
2025-09-30-128.72%
2025-06-30-61.77%
2025-03-31-34.84%
2024-12-31-45.01%
2024-09-30-37.30%
2024-06-30-50.50%
2024-03-31-63.92%
2023-12-31-122.52%
2023-09-30-79.99%
2023-06-30-71.09%
2023-03-31-48.46%
2022-12-31-37.63%
2022-09-30-44.74%
2022-06-30-55.77%
2022-03-31-71.44%
2021-12-31-61.34%

Annual ROE

DateROE
2025-12-31-55.30%
2024-12-31-45.01%
2023-12-31-122.52%
2022-12-31-37.63%
2021-12-31-61.34%
2020-12-31-44.73%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cronos Group Inc. (CRON)$1.223B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B